Hien Thi Tran

Array ( [id] => 7595458 [patent_doc_number] => 07626003 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-01 [patent_title] => 'Genetically engineered cDNA of rat bcl-x gene and an improved protein' [patent_app_type] => utility [patent_app_number] => 11/819889 [patent_app_country] => US [patent_app_date] => 2007-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 27 [patent_no_of_words] => 8500 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/626/07626003.pdf [firstpage_image] =>[orig_patent_app_number] => 11819889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 209643 [patent_doc_number] => RE041007 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2009-11-24 [patent_title] => 'Method for diagnosing selected adenocarcinomas' [patent_app_type] => reissue [patent_app_number] => 11/801428 [patent_app_country] => US [patent_app_date] => 2007-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5726 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/041/RE041007.pdf [firstpage_image] =>[orig_patent_app_number] => 11801428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4752502 [patent_doc_number] => 20080160576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'ANTI-ALPHABETA3 HUMANIZED MONOCLONAL ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 11/739755 [patent_app_country] => US [patent_app_date] => 2007-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18018 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20080160576.pdf [firstpage_image] =>[orig_patent_app_number] => 11739755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1077096 [patent_doc_number] => 07615612 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-10 [patent_title] => 'Polypeptide' [patent_app_type] => utility [patent_app_number] => 11/686793 [patent_app_country] => US [patent_app_date] => 2007-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19001 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/615/07615612.pdf [firstpage_image] =>[orig_patent_app_number] => 11686793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 333999 [patent_doc_number] => 07507410 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-24 [patent_title] => 'Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/680190 [patent_app_country] => US [patent_app_date] => 2007-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9969 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/507/07507410.pdf [firstpage_image] =>[orig_patent_app_number] => 11680190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5253957 [patent_doc_number] => 20070135413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'TREATMENT OF GLIAL TUMORS WITH GLUTAMATE ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 11/625674 [patent_app_country] => US [patent_app_date] => 2007-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10953 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20070135413.pdf [firstpage_image] =>[orig_patent_app_number] => 11625674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 123509 [patent_doc_number] => 07705131 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-27 [patent_title] => 'Method for diagnosing selected adenocarcinomas' [patent_app_type] => utility [patent_app_number] => 11/654074 [patent_app_country] => US [patent_app_date] => 2007-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5738 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/705/07705131.pdf [firstpage_image] =>[orig_patent_app_number] => 11654074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 123508 [patent_doc_number] => 07705130 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-27 [patent_title] => 'Antibodies directed to HER-3 and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/649722 [patent_app_country] => US [patent_app_date] => 2007-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 28007 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/705/07705130.pdf [firstpage_image] =>[orig_patent_app_number] => 11649722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5095099 [patent_doc_number] => 20070116708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/641633 [patent_app_country] => US [patent_app_date] => 2006-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 32185 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20070116708.pdf [firstpage_image] =>[orig_patent_app_number] => 11641633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5235956 [patent_doc_number] => 20070128112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/641128 [patent_app_country] => US [patent_app_date] => 2006-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 32540 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20070128112.pdf [firstpage_image] =>[orig_patent_app_number] => 11641128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5172609 [patent_doc_number] => 20070073042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Novel MHC II associated peptides' [patent_app_type] => utility [patent_app_number] => 11/602144 [patent_app_country] => US [patent_app_date] => 2006-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15037 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20070073042.pdf [firstpage_image] =>[orig_patent_app_number] => 11602144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 337761 [patent_doc_number] => 07504102 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-17 [patent_title] => 'Anti-αvβ3 humanized monoclonal antibodies' [patent_app_type] => utility [patent_app_number] => 11/582745 [patent_app_country] => US [patent_app_date] => 2006-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 13 [patent_no_of_words] => 18014 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/504/07504102.pdf [firstpage_image] =>[orig_patent_app_number] => 11582745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5050939 [patent_doc_number] => 20070031484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Immunoliposomes that optimize internationalization into target cells' [patent_app_type] => utility [patent_app_number] => 11/546781 [patent_app_country] => US [patent_app_date] => 2006-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14068 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20070031484.pdf [firstpage_image] =>[orig_patent_app_number] => 11546781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5062563 [patent_doc_number] => 20070224202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'USE OF ANTIBODIES FOR THE VACCINATION AGAINST CANCER' [patent_app_type] => utility [patent_app_number] => 11/548269 [patent_app_country] => US [patent_app_date] => 2006-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8469 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20070224202.pdf [firstpage_image] =>[orig_patent_app_number] => 11548269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5236008 [patent_doc_number] => 20070128164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'POLYPEPTIDE' [patent_app_type] => utility [patent_app_number] => 11/532816 [patent_app_country] => US [patent_app_date] => 2006-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19009 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20070128164.pdf [firstpage_image] =>[orig_patent_app_number] => 11532816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5172385 [patent_doc_number] => 20070072818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Regulation of angiogenesis with zinc finger proteins' [patent_app_type] => utility [patent_app_number] => 11/486994 [patent_app_country] => US [patent_app_date] => 2006-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 45301 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20070072818.pdf [firstpage_image] =>[orig_patent_app_number] => 11486994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5219769 [patent_doc_number] => 20070161080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-12 [patent_title] => 'Antibodies' [patent_app_type] => utility [patent_app_number] => 11/482552 [patent_app_country] => US [patent_app_date] => 2006-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 27051 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20070161080.pdf [firstpage_image] =>[orig_patent_app_number] => 11482552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5922301 [patent_doc_number] => 20060240470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Gene causative of Rothmund-Thomson syndrome and gene product' [patent_app_type] => utility [patent_app_number] => 11/477604 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15220 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240470.pdf [firstpage_image] =>[orig_patent_app_number] => 11477604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 151142 [patent_doc_number] => 07682785 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-23 [patent_title] => 'Method for predicting effectiveness of chemotherapy using anticancer agent' [patent_app_type] => utility [patent_app_number] => 11/474981 [patent_app_country] => US [patent_app_date] => 2006-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13009 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/682/07682785.pdf [firstpage_image] =>[orig_patent_app_number] => 11474981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585933 [patent_doc_number] => 20090105135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Therapeutic Agent for Cancer' [patent_app_type] => utility [patent_app_number] => 11/917706 [patent_app_country] => US [patent_app_date] => 2006-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3147 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105135.pdf [firstpage_image] =>[orig_patent_app_number] => 11917706 [rel_patent_id] =>[rel_patent_doc_number] =>)